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APOE genetics influence murine
gut microbiome
Diana J. Zajac1, Stefan J. Green2,4, Lance A. Johnson1 & Steven Estus1,3*
Apolipoprotein E (APOE) alleles impact pathogenesis and risk for multiple human diseases, making
them primary targets for disease treatment and prevention. Previously, we and others reported
an association between APOE alleles and the gut microbiome. Here, we evaluated effects of APOE
heterozygosity and tested whether these overall results extended to mice maintained under ideal
conditions for microbiome analyses. To model human APOE alleles, this study used APOE targeted
replacement (TR) mice on a C57Bl/6 background. To minimize genetic drift, homozygous APOE3 mice
were crossed to homozygous APOE2 or homozygous APOE4 mice prior to the study, and the resulting
heterozygous progeny crossed further to generate the study mice. To maximize environmental
homogeneity, mice with mixed genotypes were housed together and used bedding from the cages
was mixed and added back as a portion of new bedding. Fecal samples were obtained from mice
at 3-, 5- and 7-months of age, and microbiota analyzed by 16S ribosomal RNA gene amplicon
sequencing. Linear discriminant analysis of effect size (LefSe) identified taxa associated with APOE
status, depicted as cladograms to show phylogenetic relatedness. The influence of APOE status was
tested on alpha-diversity (Shannon H index) and beta-diversity (principal coordinate analyses and
PERMANOVA). Individual taxa associated with APOE status were identified by classical univariate
analysis. Whether findings in the APOE mice were replicated in humans was evaluated by using
published microbiome genome wide association data. Cladograms revealed robust differences
with APOE in male mice and limited differences in female mice. The richness and evenness (alphadiversity) and microbial community composition (beta-diversity) of the fecal microbiome was robustly
associated with APOE status in male but not female mice. Classical univariate analysis revealed
individual taxa that were significantly increased or decreased with APOE, illustrating a stepwise
APOE2-APOE3–APOE4 pattern of association with heterozygous animals trending as intermediate in
the stepwise pattern. The relative abundance of bacteria from the class Clostridia, order Clostridiales,
family Ruminococacceae and related genera increased with APOE2 status. The relative abundance
of Erysipelotrichia increased with APOE4 status, a finding that extended to humans. In this study,
wherein mice were maintained in an ideal fashion for microbiome studies, gut microbiome profiles
were strongly and significantly associated with APOE status in male APOE-TR mice. Erysipelotrichia
are increased with APOE4 in both mice and humans. APOE allelic effects appeared generally
intermediate in heterozygous animals. Further evaluation of these findings in humans, as well as
studies evaluating the impact of the APOE-associated microbiota on disease-relevant phenotypes, will
be necessary to determine if alterations in the gut microbiome represent a novel mechanism whereby
APOE alleles impact disease.
Apolipoprotein E (APOE) alleles impact multiple facets of the human condition, ranging from Alzheimer’s
disease (AD) to cardiovascular disease, metabolic syndrome, obesity, fertility and longevity (reviewed in Ref.1).
The three primary APOE alleles include APOE3, which has a 78% minor allele frequency, as well as APOE4 and
APOE2, with minor allele frequencies of 14 and 8%, respectively. Regarding AD, APOE2 reduces AD risk while
APOE4 strongly increases AD risk, both relative to APOE3 (reviewed in Ref.2). This association has prompted
intense evaluation of possible mechanism(s) underlying APOE effects in AD, resulting in APOE allelic association
with amyloid-beta (Aβ) clearance, Aβ aggregation and astrocyte stress3–8. In the periphery, APOE2 is associated
with decreased low-density lipoprotein (LDL) cholesterol, whereas APOE4 is associated with increased LDL
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cholesterol, relative to APOE3. While this may account for APOE association with cardiovascular disease, the
mechanisms underlying APOE allelic effects on glucose metabolism, inflammation and innate immunity are
less clear2. The effects of APOE alleles in heterozygous individuals are generally intermediate for phenotypes
ranging from cholesterol to A
 D1,2. Elucidating these differential actions of APOE alleles may provide insights
to these processes.
Several studies have suggested a relationship between APOE status, the gut microbiome and AD neuropathology. First, APOE-deficient mice display microbiome differences relative to wild-type mice9. Second, APOE4targeted replacement (TR) mice were more resistant to gastrointestinal Cryptosporidium infection than APOE3
mice10. Third, the APOE4 allele in humans was associated with better defense against childhood diarrheal diseases in lower income c ountries11–13. Fourth, we and others have recently reported microbiome differences in a
comparison of APOE3 and APOE4-TR mice14–16. Lastly, several reports have found that Aβ-burden in murine
models is reduced in gnotobiotic mice or mice treated with a ntibiotics17–20. The mechanism(s) whereby APOE
alleles influence the gut microbiome are unclear, although APOE4 has been associated with a greater inflammatory response to lipopolysaccharide (LPS), a microbiome product common to all gram-negative bacteria, in
both humans and mice21,22.
To begin to evaluate whether APOE allelic effects are dominant, co-dominant, or recessive, we compared
animals heterozygous and homozygous for APOE alleles. Additionally, we improved our study design for rigor
and reproducibility by backcrossing the APOE-TR mice to obviate possible genetic drift, maintaining mice with
mixed genotypes in the same cages to minimize possible cage effects, and mixing used bedding between cages
to ensure a homogenous microbial environment among cages.

Materials and methods

Mice. APOE3-TR23,24 male mice were crossed to APOE4 and APOE2 female mice to produce APOE2/E3

and APOE3/E4 heterozygous offspring. These mice were then crossed to generate 76 experimental mice that
included APOE2/E2 (N = 6), APOE2/E3 (N = 12), APOE3/E3 (N = 5), APOE3/E4 (N = 8), and APOE4/E4 (N = 4)
female mice and APOE2/E2 (N = 5), APOE2/E3 (N = 7), APOE3/E3 (N = 13), APOE3/E4 (N = 11), and APOE4/
E4 (N = 5) male mice. Genotypes were determined by TaqMan SNP assays (Thermo). At weaning, mice were
separated by sex and housed as mixed genotypes, 2–5 mice per cage (average of 3.7 ± 1.4 (mean ± SD)). Mice
were maintained on Teklad Global 18% Protein Rodent Diet. To minimize potential confounding effects of
coprophagy (mice feeding partially on cage-mate feces)25, approximately 20% of the new bedding was a mixture
of used bedding from all the cages. Feces were obtained from this cohort of mice at 3-, 5- and 7-months of age. To
obtain feces, mice were temporarily removed from their cage and placed into a clean Styrofoam cup. Fresh fecal
pellets were stored at − 80 °C until DNA isolation. All methods were approved by University of Kentucky Institutional Animal Care and Use Committee. This study was carried out in compliance with ARRIVE guidelines.

Microbiome analysis. Fecal DNA was isolated by using a QIAamp PowerFecal Pro DNA Kit (QIAGEN).
Genomic DNA was polymerase chain reaction (PCR) amplified with primers CS1_515F and CS2_806R (modified from the primer set employed by the Earth Microbiome Project (EMP; GTGYCAGCMGCCGCGGTAA and
GGACTACNVGGGTWTCTAAT) targeting the V4 regions of microbial small subunit ribosomal RNA genes
were generated using a two-stage PCR amplification protocol as described previously26. The primers contained
5′ common sequence tags (known as common sequence 1 and 2, CS1 and CS2). First stage PCR amplifications
were performed in 10 µl reactions in 96-well plates, using MyTaq HS 2× mastermix (Bioline). PCR conditions
were 95 °C for 5 min, followed by 28 cycles of 95 °C for 30′′, 55 °C for 45′′ and 72 °C for 60′′.
Subsequently, a second PCR amplification was performed in 10 µl reactions in 96-well plates. A mastermix
for the entire plate was made using MyTaq HS 2× mastermix. Each well received a separate primer pair with a
unique 10-base barcode, obtained from the Access Array Barcode Library for Illumina (Fluidigm, South San
Francisco, CA; Item# 100-4876). Cycling conditions were: 95 °C for 5 min, followed by 8 cycles of 95 °C for 30′′,
60 °C for 30′′ and 72 °C for 30′′. Samples were then pooled, purified, and sequenced on an Illumina MiniSeq
platform employing paired-end 2 × 153 base reads. Fluidigm sequencing primers, targeting the CS1 and CS2
linker regions, were used to initiate sequencing. De-multiplexing of reads was performed on instrument. Library
preparation, pooling, and sequencing were performed at the University of Illinois at Chicago Genome Research
Core (GRC) within the Research Resources Center (RRC).
Forward and reverse reads were merged using P
 EAR27 and trimmed based on a quality threshold of p = 0.01.
Ambiguous nucleotides and primer sequences were removed and sequences shorter than 225 bp were discarded.
Chimeric sequences were identified and removed using the USEARCH algorithm with a comparison to the Silva
132_16S reference d
 atabase28,29. Amplicon sequence variants (ASVs) were identified using D
 ADA230 and their
taxonomic annotations determined using the UCLUST algorithm and Silva 132_16S reference with a minimum
similarity threshold of 90%28,29. Sequence processing and annotation was performed by the Research Informatics
Core (RIC) within the RRC.
This sequencing effort yielded 10,162,042 reads. Raw sequence data files were submitted in the Sequence Read
Archive (SRA) of the National Center for Biotechnology Information (NCBI) under the BioProject Identifier
PRJNA787634. Two samples with fewer than 30,000 reads each were discarded. Since APOE effects may be sex
dependent16, microbiomes from male and female mice were analyzed separately. Average read counts per sample
for the 3-month males was 48,725, 3-month females was 49,499, 5-month males was 45,985, 5-month females
was 49,939, in 7-month males was 50,975, in 7-month females was 51,931. Using MicrobiomeAnalyst31 (updated
version February 2021), samples were rarified to the minimum library size, which for 3-month males was 36,421,
3-month females was 37,069, 5-month males to 30,738, 5-month females to 35,467, 7-month males to 35,452,
and 7-month females to 36,730. Low abundance ASVs were removed, i.e., ASVs with < 3 counts in > 90% of the
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samples were removed, and low variance ASVs were also removed, i.e., ASVs whose inter-quantile range was in
the lowest 10%31. These corrections reduced the number of ASVs from 263 to 63 ASVs in 3-month males and
females, 67 in 5-month females, 69 in 5-month males, 68 in 7-month females and 66 in 7-month males. Count
data were normalized with a centered log-ratio transformation. Regarding APOE genetics, the results were analyzed as separate genotypes or as pooled alleles, i.e., APOE2/E3 heterozygous mice were grouped with APOE2/E2
mice while APOE3/E4 mice were grouped with APOE4/E4 as described in other APOE studies32,33. This resulted
in 12 APOE2, 13 APOE3 and 16 APOE4 male mice and 18 APOE2, five APOE3 and 12 APOE4 female mice.
Bacteria associated with APOE were identified by a linear discriminant analysis effect size (LefSe) a pproach34.
Significance thresholds were set to 0.05 for the alpha values for Kruskal–Wallis/Wilcoxon tests and 2.0 for the
logarithmic linear discriminant analysis (LDA) score, using a one-against-all multi-class analysis approach. These
results were then plotted as a cladogram to document the phylogenetic relatedness of APOE allelic associations
with the bacteria at each taxonomic level. Results are also presented as an LDA histogram.
Alpha-diversity was assessed using the Shannon H diversity i ndex35 with APOE statistical significance determined by Kruskal–Wallis tests. Additional alpha-diversity tests included Margalef taxon richness, Pielou’s evenness and the Simpson index with APOE statistical significance determined by Jonckheere–Terpstra nonparametric tests. Beta-diversity was assessed using Principal Coordinates Analysis (PCoA) of Bray–Curtis matrices
with statistical significance determined by Permutational Multivariate Analysis of Variance (PERMANOVA)36.
Taxonomic levels that associate with APOE status were determined using a classical univariate analysis with a
Kruskal–Wallis test. A false discovery rate (FDR) approach was used to correct for multiple testing31. Heatmaps
of family-level bacterial relative abundances were generated for male and female mice as a function of APOE
status by using the Ward analysis of variance clustering algorithm, which is based on Pearson Correlation Coefficient distance measures.

Ethics approval. Animal studies were performed in compliance with the Institutional Animal Care and Use
Committee at University of Kentucky.
Consent for publication. Each of the authors have reviewed the manuscript and approved it for publica-

tion.

Results

To investigate the hypothesis that APOE is associated with gut microbial community structure, we began with
LefSe analysis and visualized the results with cladograms (Figs. 1, 2, Figs. S1, S2). This robust approach provides a visual means to identify statistically significant and phylogenetically-related taxa associated with APOE
status34. These LefSe results are also presented as LDA histograms to provide a quantitative representation of
the LefSe analyses (Fig. S3). Results are presented with APOE status stratified as APOE2 carriers, APOE3 and
APOE4 carriers (pooled) (Figs. 1A, 2A) and with APOE status as separate genotypes (Figs. 1B, 2B). These two
representations of the data provide insights into whether APOE allelic effects are dominant or co-dominant.
Robust gut microbiome differences were observed in male mice compared to female mice at 3-months of age
(Figs. 1, 2) with similar results found at 5- and 7-months of age (Figs. S1, S2). The microbiome of both male
and female mice showed APOE4-associated increases in members of the Actinobacteria phylum (Figs. 1, 2). In
contrast, only male mice showed APOE4-associated increases in the Erysipleotrichia and Gammaproteobacteria
classes and APOE2-associated increases in the Cyanobacteria phylum. To gain further insights into these findings, we parsed the results into individual genotypes. This expanded our findings by showing that members of
the Clostridia class were significantly associated with APOE2/E2 and APOE2/E3 (Fig. 1B). Overall, these results
indicated that a subset of bacteria were consistently associated with APOE status, especially in males. The male
population captured the majority of taxa significantly associated with APOE in the female population. In the
following results, we present analyses of data from male mice at 3-months of age with analyses for all ages and
sexes included within the Supplemental Files.
Microbiome alpha- (within sample) diversity was assessed by the Shannon H index and Simpson index,
measures of taxon richness and evenness, as well the Margalef taxon richness index and evenness index37. A
robust association between alpha-diversity and APOE was not detected in female mice (Shannon index p-values
in Table 1, all measures of alpha-diversity in Supplemental Files). In contrast, male mice showed a stepwise trend
towards higher alpha-diversity with APOE2-APOE3-APOE4 at the genus level, and this trend became more
defined and statistically significant at every higher level through phylum (phylum and family depicted in Fig. 3,
all levels presented in Table 1 and Supplemental Files, additional ages, and female data in Table S1). When the
results are parsed into separate genotypes, the alpha-diversity of the APOE heterozygous animals tended to be
intermediate relative to the homozygous animals. Hence, APOE was associated with alpha-diversity in male but
not female mice and APOE allelic affects appeared co-dominant.
Beta-diversity is a measure of between sample microbial communities based on their composition. Betadiversity was visualized by using PCoA based on Bray–Curtis distance m
 atrices38–41, and analyzed using a PERMANOVA. We found that APOE status was significantly associated with microbiome beta-diversity in male
mice (Fig. 3, Table 2, additional ages and female in Table S2). When the data were analyzed with each separate
APOE genotype, beta-diversity was still significant at each of the same taxonomic levels. Overall, these results
demonstrate that the microbiome is robustly associated with APOE genetics in male mice.
Variation in bacterial relative abundance per sample was visualized using heatmaps, as seen in Fig. 4. While
cladograms identify bacterial phylogenetic branches that correlate with high abundance in association with a
specific APOE status, heatmaps provide a per sample depth of information for each APOE status. Inspection of
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Figure 1.  Cladograms reveal microbial phylogenetic branches associated with APOE status in males. Taxa are
represented as nodes and are connected by lines based on the phylogenetic relatedness of all taxa present in each
experimental cohort. For example, the end node, a. represents the genus Bifodobacterium which is connected to
other nodes representing higher level taxa related to Bifodobacterium including; b. the family Bifidobacteriaceae, c.
the order Bifidobacteriales, and d. the class Actinobacteria. Many taxa are associated with APOE genetics, with node
colors indicating the APOE associated with highest levels of that taxa. Statistical significance reflects both p < 0.05 for
Kruskal–Wallis tests and a logarithmic LDA score > 2.0.
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Figure 2.  Cladograms reveal microbial phylogenetic branches associated with APOE status in females. Taxa
significantly associated with APOE are highlighted (p < 0.05 for Kruskal–Wallis tests and a logarithmic LDA
score > 2.0).

the heatmaps suggests that the data are relatively complex although some patterns of taxa association with APOE
status are discernible, e.g., Ruminococcaceae and Erysipelotrichaceae in male mice (Fig. 4).
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Alpha-diversity (Shannon index)
3 month p-values
Taxanomic level

Males dominant

Males co-dominant

Feature

4.01E−01

1.02E−01

Genus

4.01E−01

1.02E−01

Family

5.49E−04

3.81E−03

Order

7.68E−05

5.05E−04

Class

7.68E−05

5.05E−04

Phylum

9.77E−05

1.28E−04

Table 1.  Microbiome alpha-diversity was significantly associated with APOE status in 3-month male but not
female mice. P-values reflect nominal p-values and were determined using Kruskal–Wallis tests. Values for
5- and 7-month male mice and female mice are presented in Tables S1 and S2. Raw data for alpha-diversity
indices are provided in Supplemental Files. Significance p-values are in bold font.

Figure 3.  Microbiome alpha- and beta-diversity as a function of APOE. Alpha-diversity is depicted as
boxplots (A,B,D,E) and beta-diversity as PCoA plots (C,F). These results are from male mice at 3-months of
age. Statistical significance for the findings is indicated below each graph. Ellipses in C and F represent 95%
confidence intervals. Dominant model (C) R2 = 0.171 and co-dominant model (F) R2 = 0.206. Beta-diversity
was also analyzed using a PERMDISP, which had no significant p-values, indicating that variances were not
significantly different as a function of APOE.
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Beta-diversity (PERMANOVA)
3 month
Taxanomic level
Feature
Genus
Family
Order
Class
Phylum

p-value
R2
p-value
R2
p-value
R2
p-value
R2
p-value
R2
p-value
R2

Males -dominant
< 0.002

Males co-dominant
< 0.004

0.14

0.20

< 0.001

< 0.008

0.15

0.18

< 0.004

< 0.013

0.17

0.21

< 0.004

< 0.015

0.21

0.24

< 0.004

< 0.015

0.21

0.24

< 0.035

< 0.112

0.12

0.15

Table 2.  Microbiome beta-diversity significantly associated with APOE status in male, but not female, mice.
The R2 values represent the proportion of the variance captured by APOE alleles. The PERMANOVA results
were derived from 999 permutations. Values for 5- and 7-month male mice and female mice are contained
within Tables S3 and S4. Significance p-values are in bold font.

Figure 4.  Heatmaps depict overall microbiota profiles grouped by APOE status. These heatmaps depict persample relative abundance for family-level bacteria in female and male mice. Columns were grouped by APOE
status, rows were grouped by the Ward clustering algorithm using Pearson Correlation Coefficient distance
measures. Colored boxes highlight groups of taxa that follow either an APOE2- (A.2 and B.2), APOE3- (A.3 and
B.3) or APOE4-associated pattern (A.4 and B.4).

Although the use of LefSe analysis and cladograms provides insights into the microbiome and have been
optimized for this p
 urpose34, another perspective is provided by taxon-by-taxon classical univariate analysis
using a Kruskal–Wallis test for significance and an FDR correction for multiple testing. To highlight the taxa
most robustly associated with APOE, we applied classical univariate analysis to identify results that were significant with both approaches. Classical univariate analysis of the 3-month old female mice found no ASVs,
genera, families, orders, classes, or phyla that were significantly associated with APOE in either APOE model.
However, this approach applied to 3-month old male mice in the dominant model found 12 APOE-associated
ASVs, as well as 12 genera, six families, five orders, five classes, and one phylum (statistics for all taxa in each
age group are listed in Supplementary Tables S1.1–S3.4). In the co-dominant model, this approach found eight
ASVs, eight genera, three families, four orders, four classes, and no phyla that were significantly associated with
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Figure 5.  The phylogenetic branch defined by Clostridia and its lower taxa shows a significant association
with APOE in male mice. The relative abundance of each depicted bacteria was significantly associated with
APOE status. The relative abundance of these bacteria decreased in a stepwise fashion from APOE2 to APOE3 to
APOE4. P values have been corrected using an FDR approach. (A–D) Are the plots depicted using the dominant
model representation, while (E–H) are the plots depicted using the co-dominant model representation. These
data are derived from the 3-month male mice with data for all ages provided in Supplementary Tables S5.0–
SS7.5.

APOE. A graphical representation of the findings in 3-month old male mice is depicted in Fig. 5. Several bacteria
showed stepwise associations with APOE on multiple taxonomic levels and were overall increased with APOE2.
For example, the Clostridia class, Clostridiales order and two major families within this phylogenic branch,
Ruminococcaceae and Lachnospiraceae showed an increase in their relative abundance from APOE4 to APOE3
to APOE2 (Fig. 5). The most abundant genera within the Ruminococcaceae family significantly associated with
APOE were Ruminiclostridium (Fig. 5A,E), Ruminiclostridium_5 and Ruminiclostridium_9, which in aggregate
represent approximately half of the Ruminococcaceae family. At 5- and 7-months of age, other genera within
Ruminococcaceae were associated with APOE (Supplemental Tables S5.0–S7.5). Genera within the other major
family, Lachnospiraceae, that increased with APOE2 were Acetifactor and Lachnoclostridium (Fig. 5B,C,F,G).
In contrast, the relative abundance of other taxa was increased in APOE4 mice, most notably bacteria within
the class Erysipelotrichia class, confirming the findings from the LefSe cladograms (Fig. 1). Bacteria within the
Erysipelotrichia branch that were significantly associated with APOE included the order Erysipelotrichiales, its
family Erysipelotrichaceae and its genera Turicibacter and Dubosiella (Fig. 6, data for all ages shown in Supplementary Tables S5.0–S7.5). Consistent within this branch, bacterial relative abundance was near zero in the
APOE2 mice, moderate in APOE3 and highly enriched in APOE4 (Fig. 6). Hence, both the LefSe and classical
approaches identified members of the Clostridia class as enriched in APOE2 mice while members of the Erysipelotrichia class were enriched in APOE4 mice.
To discern whether the Clostridiales and Erysipelotrichiales phylogenetic branches associated with APOE in
this murine APOE-TR model are also associated with APOE in humans, we turned to a recent genome wide association study (GWAS) that evaluated the relationship between the gut microbiome and human p
 olymorphisms42.
This meta-analysis included data from as many as 18,340 individuals42. The only genetic locus that reached
genome wide statistical significance was rs182549, which is associated with lactose intolerance. Interestingly,
this SNP is modestly associated with the risk of Alzheimer’s disease (p = 0.003, N = 445,779)43, consistent with
the possibility that the gut microbiome may influence AD risk. Focusing on APOE, the alleles of APOE2, APOE3
and APOE4 are defined by two SNPs, rs7412 and rs429358. The minor allele of rs7412 defines APOE2 while
the minor allele of rs429358 determines APOE4 status. The Clostridiales and Erysipelotrichiales phylogenetic
branches were not significantly associated with rs7412 (APOE2) at any phylogenetic level. However, the class
Erysipelotrichia, the order Erysipelotrichales and the family Erysipelotrichaceae were nominally associated with
rs429358 (Table 3). For each of these taxa, the minor APOE4 allele was associated with an increase in the relative
abundance of these bacteria, reproducing the findings observed in the murine APOE-TR model.

Discussion

The primary finding reported here is that murine gut microbiome profiles are significantly associated with APOE
status and APOE alleles appeared to act in a co-dominant fashion in heterozygous mice. These findings are
strengthened given that the APOE-TR mice were maintained in an optimized fashion for microbiome analyses.
Scientific Reports |
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Figure 6.  The phylogenetic branch defined by Erysipelotrichia and its lower taxa shows a significant association
with APOE in male mice. All depicted bacteria were significantly associated with APOE status. The relative
abundance of these bacteria increased in a stepwise fashion from APOE2 to APOE3 to APOE4. P values have
been corrected using an FDR approach. (A–C) Are the plots depicted using the dominant model representation,
while (D–F) are the plots depicted using the co-dominant model representation. These results are derived from
3-month male mice.
Bacteria

SNP

Reference Allele

Effect Allele

Beta

SE

p value

N

Class: Erysipelotrichia

rs429358

T

C

0.032

0.015

0.035

18,097

Order: Erysipelotrichales

rs429358

T

C

0.032

0.015

0.035

18,097

Family: Erysipelotrichaceae

rs429358

T

C

0.032

0.015

0.035

18,097

Genus: Turicibacter

rs429358

T

C

0.001

0.021

0.87

8921

Table 3.  Bacteria in the Erysipelotrichia phylogenetic branch are nominally associated with rs429358 in
humans. The positive beta values reflect that the bacterial taxa are increased with the minor APOE4 allele
of rs429358. These results combine data from men and women and are supplemental data from a large
microbiome genetics study42. Significance p values are in bold font.

The microbiome association with APOE was observed in alpha- and beta-diversity, encompasses multiple bacterial lineages and was predominately observed in male mice. Both LefSe and classical univariate analyses identified
specific taxa that were associated with APOE. This association occurred in a stepwise fashion in the mice with
the progression from APOE2-APOE3-APOE4. The stepwise association between indices of the gut microbiome
and APOE2-APOE3-APOE4 reported here are reminiscent of APOE allelic association with other phenotypes
ranging from LDL-cholesterol to AD risk1,2. Additionally, at least one of these associations, an increase in the
relative abundance of Erysipelotrichia with APOE4, also has been observed in the human gut microbiome42.
Moreover, the stepwise trends were also seen in the heterozygous mice, which reflected resulting intermediate
effects of APOE on the gut microbiome. Overall, these findings confirm and extend prior reports that APOE
genetics are associated with the gut m
 icrobiome14–16.
To identify the impact of APOE alleles on the microbiome, we used several approaches in this study, including alpha-diversity, beta-diversity, LefSe and classical univariate analyses. Alpha- and beta-diversity analyses
aggregate multiple variables to provide an assessment of overall microbiome diversity and of microbiome profile
similarity, respectively. In contrast, LefSe and classical univariate analyses provide an indication of differences in
the relative abundance of specific taxa between experimental groups. These analyses were done by pooling the
genotypes in a way representative of a dominant model of allelic effect and as individual genotypes representative
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of a co-dominant model of allelic effect. In this discussion, we will highlight the primary significant findings
from these various analyses.
APOE4 was associated with increased alpha-diversity as assessed by the Shannon H index. A stepwise progression was observed in the dominant model representation with lowest alpha-diversity in APOE2, moderate
in APOE3 and highest in APOE4. The co-dominant model representation showed an intermediate effect in the
heterozygous animals following the stepwise APOE trend. Alpha-diversity is a measure of the number of distinct
taxa and the evenness of these numbers across taxa. High alpha-diversity in the gut microbiome has been associated with improved gut health and microbiome homeostasis (reviewed in Ref.44). The APOE4 association with
increased alpha-diversity observed here is consistent with prior observations that APOE4 is associated with better
response to diarrheal infections in a third-world e nvironment12,13. Indeed, the enrichment of APOE4 in people
indigenous to Amazonian basin has been proposed to be a result of evolutionary selection in this environment
with insufficient s anitation45.
A primary finding of this study was that both the LefSe and classical univariate analyses found that taxa within
the Clostridia class were increased with APOE2 status, confirming results from our prior s tudy14 and that of Tran
et al.15. This phylogenetic branch included the Clostridiales order, Ruminococcaceae family and several genera
within this family. The Clostridiales order was increased in APOE2 mice compared to APOE3 and APOE4 mice,
with the heterozygous mice as intermediates. This was most robust in the 3-month males with similar findings
at 5- and 7-months. The two major bacterial families within this order, Ruminococcaceae and Lachnospiraceae,
were also both increased with APOE2. The stepwise fashion of the decline in Ruminnococcaceae relative abundance from APOE2 to APOE3 to APOE4 confirms the stepwise pattern seen previously14,16 and extends it along
the phylogenetic branch from the Clostridia class to associated genera, such as Ruminiclostridium, Ruminiclostridium_5, Ruminiclostridium_9. Interestingly, Tran et al. also reported an increase in relative abundance of
the Clostridiales order and Ruminococcaceae family in APOE2/E3 humans compared to APOE3/E4 and APOE4/
E4 humans15. This suggests that this increase in Clostridiales and Ruminococcaceae with APOE2 may extend to
humans. Two additional genera in the Clostridia class, within the Lachnospiraceae family, i.e., Acetifactor and
Lachnoclostridium, also increased with APOE2 status in the current study. However, this finding was not replicated by Tran et al., who reported that Lachnospiraceae increased in APOE4 mice compared to APOE3 mice15.
Our study strengthens the associations between APOE status and the Clostridiales order, Ruminococcaceae
family and related genera, and the Acetifactor and Lachnoclostridium genera by demonstrating a stepwise pattern
with APOE allelic status across the entire phylogenetic branch from the Clostridia class down to related genera. Ruminococcaceae and Lachnospiraceae are bacterial families that highly express genes responsible for the
metabolism of resistant starches in the large intestine, generating short chain fatty acids (SCFAs). The presence
of SCFAs in the gut affect human health in general (reviewed in Refs.46,47) and have been reported to promote
microglial maturation and function in particular48. Treatment with SCFAs has been shown to reduce microglial
pro-inflammatory signals and promote a homeostatic profile that is neuroprotective49–52. Considering these findings relative to disease pathology associated with the stepwise APOE2-APOE3-APOE4 phenotype, we propose
a tentative model wherein (i) APOE2 is associated with an increase in the relative abundance of microbiome
bacteria Ruminococcaceae, Acetifactor and Lachnoclostridium, relative to APOE3 and APOE4, (ii) this shift in
bacterial profile increases the production of SCFAs and (iii) this increase in SCFAs promotes microglial homeostasis and disease-ameliorating signaling, as suggested by robust genetic e vidence53–61, (reviewed in Refs.62,63).
While speculative, this model serves as a framework for future studies.
Another primary finding detected by both the LefSe and classical univariate analyses was that the Erysipelotrichia phylogenetic branch was significantly associated with APOE status in a stepwise APOE2-APOE3-APOE4
pattern with heterozygous mice acting as intermediates. This finding appeared to extend to humans and replicates
the increase of the Erysipelotrichaceae family in APOE4 mice that we observed p
 reviously14. This parallels the
association of the Erysipelotrichia class, Erysipelotrichales order and Erysipelotrichaceae family with the APOE4
minor allele rs429358 in human GWAS data. Our current study also extends this finding from the Erysipelotrichia phylogenetic order to its major genera, i.e., Turicibacter and Dubosiella. However, Tran et al. reported
Erysipelotrichaceae were significantly increased in APOE3 compared to APOE4 mice. Erysipelotrichaceae has
been shown to increase in animals fed a high-fat diet and to decrease in patients on a low-fat diet64,65. Hence, diet
variation between the mice in our study and those of Tran et al. may account for the Erysipelotrichaceae difference, noting that our Teklad Global 18% (2018) chow has a fat content that accounts for 18% of total calories,
whereas the RPM3, Special Diet Services chow used in the Tran et al. study has a fat content that accounts for
12% of total calories15. Since APOE genetics have been associated with BMI and obesity1, there may be a complex
interplay between diet, APOE genotype and relative abundance of Erysipelotrichaceae in the gut.
Although the cladograms depict these results as phylogenetic trees, and the relatedness of taxa could imply
functional relatedness, a limitation of this study is that findings were not extended to a functionality analysis. A
future extension of these findings would be an in-depth analysis of the functional phenotypes of the significantly
associated taxa. Future metabolomic studies would provide information regarding differences in the gut as a
function of APOE genetics.

Conclusions

In this study in which mice were maintained with optimized conditions for microbiome analysis, we report a
significant association between APOE status and gut microbiome profiles in 3-month male mice that reproduces
at 5- and 7-months of age. The Clostridia class, Clostridiales order, its related family Ruminococcaceae, as well as
related genera Ruminoclostridium, and Acetifactor and Lachnoclostridium of the Lachnopsiraceae family, increase
with APOE2, which may reflect an increase in resistant starch metabolism with APOE2, and a possible impact
on SCFA levels. The Erysipelotrichia class, Erysipelotrichiales order, Erysipelotrichaceae family, and Turicibacter
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and Dubosiella genera increase with APOE4. The findings with the Erysipelotrichia phylogenetic branch appear
to extend to humans. Both the dominant model representation and the co-dominant model representation of
the data showed stepwise APOE effects on the gut microbiome, and the comparison of the two provides a more
robust understanding of the allelic effects. Understanding the effects of APOE genetics on the gut microbiome
may provide novel approaches to counter deleterious APOE genetic effects on human disease.

Data availability

Raw sequence data (FASTQ files) were deposited in the National Center for Biotechnology Information (NCBI)
Sequence Read Archive (SRA), under the BioProject identifier PRJNA787634.
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